Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.

Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C.

Semin Arthritis Rheum. 2012 Oct;42(2):179-85. doi: 10.1016/j.semarthrit.2012.03.011.

PMID:
22595642
2.

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR.

J Rheumatol. 2003 May;30(5):985-92.

PMID:
12734893
3.

Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.

Singh S, Gupta MK, Ahluwalia J, Singh P, Malhi P.

Rheumatol Int. 2009 Oct;29(12):1455-61. doi: 10.1007/s00296-009-0887-6.

PMID:
19306097
4.

A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.

Ho RC, Thiaghu C, Ong H, Lu Y, Ho CS, Tam WW, Zhang MW.

Autoimmun Rev. 2016 Feb;15(2):124-38. doi: 10.1016/j.autrev.2015.10.003. Review.

PMID:
26497108
5.
6.

A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus.

Avcin T, Benseler SM, Tyrrell PN, Cucnik S, Silverman ED.

Arthritis Rheum. 2008 Feb 15;59(2):206-13. doi: 10.1002/art.23334.

7.

Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus.

Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM.

Clin Rheumatol. 2008 Nov;27(11):1377-85. doi: 10.1007/s10067-008-0921-1.

PMID:
18481154
8.

The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

Sibbitt WL Jr, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, Brooks WM.

J Rheumatol. 2002 Jul;29(7):1536-42.

PMID:
12136916
9.

Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.

Padovan M, Castellino G, Bortoluzzi A, Caniatti L, Trotta F, Govoni M.

Rheumatol Int. 2012 Jan;32(1):129-35. doi: 10.1007/s00296-010-1565-4.

PMID:
20676648
10.

Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies.

Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Laganà B, Caccavo D, Ferri GM, Amoroso A, Francia A.

Neurology. 2003 Jul 8;61(1):108-10.

PMID:
12847168
11.

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies.

Harel L, Sandborg C, Lee T, von Scheven E.

J Rheumatol. 2006 Sep;33(9):1873-7.

PMID:
16845706
12.

Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.

Magro-Checa C, Schaarenburg RA, Beaart HJ, Huizinga TW, Steup-Beekman GM, Trouw LA.

Lupus. 2016 Jul;25(8):878-88. doi: 10.1177/0961203316643170.

PMID:
27252265
13.

Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus.

Hawro T, Bogucki A, Krupińska-Kun M, Maurer M, Woźniacka A.

PLoS One. 2015 Mar 17;10(3):e0119911. doi: 10.1371/journal.pone.0119911.

14.

Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.

Pradhan V, Patwardhan M, Rajadhyaksha A, Dhawale N, Ghosh K.

Rheumatol Int. 2015 Mar;35(3):541-5. doi: 10.1007/s00296-014-3114-z.

PMID:
25119833
15.

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.

Mikdashi J, Handwerger B.

Rheumatology (Oxford). 2004 Dec;43(12):1555-60.

PMID:
15342927
16.

Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.

Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.

Scand J Rheumatol. 2007 Nov-Dec;36(6):442-7.

PMID:
18092265
17.

Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome.

Zandman-Goddard G, Chapman J, Shoenfeld Y.

Semin Arthritis Rheum. 2007 Apr;36(5):297-315. Review.

PMID:
17258299
18.

Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause.

Steup-Beekman GM, Zirkzee EJ, Cohen D, Gahrmann BM, Emmer BJ, Steens SC, Bollen EL, van Buchem MA, Huizinga TW.

Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii76-9. doi: 10.1136/annrheumdis-2012-202369.

PMID:
23253914
19.

Clinical and serologic factors associated with lupus pleuritis.

Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, Tucker LB, Petty RE; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS)., Peschken CA.

J Rheumatol. 2010 Apr;37(4):747-53. doi: 10.3899/jrheum.090249.

PMID:
20110526
20.

Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.

Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G.

J Neurol. 2014 Sep;261(9):1706-14. doi: 10.1007/s00415-014-7406-8. Review.

PMID:
24952022

Supplemental Content

Support Center